Biological optimization of simultaneous boost on intra-prostatic lesions (DILs): Sensitivity to TCP parameters

被引:16
作者
Azzeroni, R. [1 ]
Maggio, A. [1 ]
Fiorino, C. [1 ]
Mangili, P. [1 ]
Cozzarini, C. [1 ]
De Cobelli, F. [1 ]
Di Muzio, N. G. [1 ]
Calandrino, R. [1 ]
机构
[1] Ist Sci San Raffaele, I-20132 Milan, Italy
来源
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS | 2013年 / 29卷 / 06期
关键词
Prostate radiotherapy; Biological optimization; TCP; NTCP; INTENSITY-MODULATED RADIOTHERAPY; APPARENT DIFFUSION-COEFFICIENT; RADIATION-THERAPY; DOSE-ESCALATION; INTRAPROSTATIC LESION; PERIPHERAL ZONES; CANCER; TUMOR; TISSUE; DIFFERENTIATION;
D O I
10.1016/j.ejmp.2012.10.002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The aim of this investigation was to explore the potential of biological optimization in the case of simultaneous integrated boost on intra-prostatic dominant lesions (DIL) and evaluating the impact of TCP parameters uncertainty. Different combination of TCP parameters (TD50 and gamma 50 in the Poisson-like model), were considered for DILs and the prostate outside DILs (CTV) for 7 intermediate/high-risk prostate patients. The aim was to maximize TCP while constraining NTCPs below 5% for all organs at risk. TCP values were highly depending on the parameters used and ranged between 38.4% and 99.9%; the optimized median physical doses were in the range 94-116 Gy and 69-77 Gy for DIL and CTV respectively. TCP values were correlated with the overlap PTV-rectum and the minimum distance between rectum and DIL. In conclusion, biological optimization for selective dose escalation is feasible and suggests prescribed dose around 90-120 Gy to the DILs. The obtained result is critically depending on the assumptions concerning the higher radioresistence in the DILs. In case of very resistant clonogens into the DIL, it may be difficult to maximize TCP to acceptable levels without violating NTCP constraints. (C) 2012 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:592 / 598
页数:7
相关论文
共 31 条
[1]  
Agren-Cronqvist A, 1995, THESIS STOCKOLM U ST
[2]   HYPOFRACTIONATED BOOST WITH HIGH-DOSE-RATE BRACHYTHERAPY AND OPEN MAGNETIC RESONANCE IMAGING-GUIDED IMPLANTS FOR LOCALLY AGGRESSIVE PROSTATE CANCER: A SEQUENTIAL DOSE-ESCALATION PILOT STUDY [J].
Ares, Carmen ;
Popowski, Youri ;
Pampallona, Sandro ;
Nouet, Philippe ;
Dipasquale, Giovanna ;
Bieri, Sabine ;
Oezsoy, Orhan ;
Rouzaud, Michel ;
Khan, Haleem ;
Miralbell, Raymond .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03) :656-663
[3]   Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: Toxicity and biochemical outcomes [J].
Cahlon, Oren ;
Zelefsky, Michael J. ;
Shippy, Alison ;
Chan, Heather ;
Fuks, Zvi ;
Yamada, Yoshiya ;
Hunt, Margie ;
Greenstein, Steven ;
Amols, Howard .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (02) :330-337
[4]   Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: Implications for conformal therapy planning [J].
Cellini, N ;
Morganti, AG ;
Mattiucci, GC ;
Valentini, V ;
Leone, M ;
Luzi, S ;
Manfredi, R ;
Dinapoli, N ;
Digesu', C ;
Smaniotto, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (03) :595-599
[5]   Intensity Modulated Radiation Therapy Dose Painting for Localized Prostate Cancer Using 11C-choline Positron Emission Tomography Scans [J].
Chang, Joe H. ;
Joon, Daryl Lim ;
Lee, Sze Ting ;
Gong, Sylvia J. ;
Anderson, Nigel J. ;
Scott, Andrew M. ;
Davis, Ian D. ;
Clouston, David ;
Bolton, Damien ;
Hamilton, Christopher S. ;
Khoo, Vincent .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (05) :E691-E696
[6]   The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy [J].
De Meerleer, G ;
Villeirs, G ;
Bral, S ;
Paelinck, L ;
De Gersem, W ;
Dekuyper, P ;
De Neve, W .
RADIOTHERAPY AND ONCOLOGY, 2005, 75 (03) :325-333
[7]   Dose-volume effects for normal tissues in external radiotherapy: Pelvis [J].
Fiorino, Claudio ;
Valdagni, Riccardo ;
Rancati, Tiziana ;
Sanguineti, Giuseppe .
RADIOTHERAPY AND ONCOLOGY, 2009, 93 (02) :153-167
[8]   Intensity-modulated radiotherapy as primary therapy for prostate cancer: Report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion [J].
Fonteyne, Valerie ;
Villeirs, Geert ;
Speleers, Bruno ;
De Neve, Wilfried ;
De Wagter, Carms ;
Lumen, Nicolas ;
De Meerleer, Gert .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (03) :799-807
[9]   Validation of functional imaging with pathology for tumor delineation in the prostate [J].
Groenendaal, Greetje ;
Moman, Maaike R. ;
Korporaal, Johannes G. ;
van Diest, Paul J. ;
van Vulpen, Marco ;
Philippens, Marielle E. P. ;
van der Heide, Uulke A. .
RADIOTHERAPY AND ONCOLOGY, 2010, 94 (02) :145-150
[10]   PARAMETERS FAVORABLE TO INTRAPROSTATIC RADIATION DOSE ESCALATION IN MEN WITH LOCALIZED PROSTATE CANCER [J].
Housri, Nadine ;
Ning, Holly ;
Ondos, John ;
Choyke, Peter ;
Camphausen, Kevin ;
Citrin, Deborah ;
Arora, Barbara ;
Shankavaram, Uma ;
Kaushal, Aradhana .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (02) :614-620